TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)



Status:Recruiting
Conditions:Cancer, Cancer, Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:18 - 100
Updated:5/11/2018
Start Date:January 2015
End Date:January 2020
Contact:Sachin Wani, MD
Email:sachin.wani@ucdenver.edu
Phone:720-848-2786

Use our guide to learn which trials are right for you!

A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's
esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).

Patients will be enrolled in this study at the participating centers when evaluated in
gastro-intestinal (GI) clinics and endoscopy suites. Initial evaluation of patients will
include collection of data on demographics, assessment of risk factors such as smoking,
metabolic syndrome, family history and detailed medication history, and past surgical
history. All patients will be complete questionnaires regarding Gastroesophageal Reflux
Disease (GERD) symptoms, GERD related quality of life (QOL) and overall health related QOL.
Details of all previous endoscopic and surgical evaluation along with histopathology data
will be documented. Patients undergoing endoscopic evaluation at the participating centers
will have their endoscopic and histopathology results documented. This will include data
collection regarding use of advanced imaging techniques, details regarding tissue
acquisition, EET and adverse events. Patients undergoing esophagectomy will have surgical
details documented along with complications related to surgery. Similarly, details regarding
chemoradiation treatments will be documented .

Inclusion Criteria:

- Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal
cancer

Exclusion Criteria:

- Patients with squamous cell carcinoma
We found this trial at
4
sites
Tampa, Florida 33612
Principal Investigator: Cynthia Harris, MD
Phone: 813-745-8361
?
mi
from
Tampa, FL
Click here to add this to my saved trials
251 E Huron St
Chicago, Illinois 60611
(312) 926-2000
Principal Investigator: Srinadh Komanduri, MD
Phone: 312-695-0484
Northwestern Memorial Hospital Northwestern Memorial is an academic medical center hospital where the patient comes...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
757 Westwood Plaza
Los Angeles, California 90024
(310) 825-9111
Principal Investigator: V. Raman Muthusamy, MD
Phone: 310-825-1892
UCLA Medical Center Founded in 1955, UCLA Medical Center became Ronald Reagan UCLA Medical Center...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials